Question for the experts: Hi I have just been... - My Ovacome

My Ovacome

17,746 members19,983 posts

Question for the experts

Manchesterlady profile image
5 Replies

Hi I have just been reading about a drug called niraparp . Is anyone on this , or has heard about it ?

Written by
Manchesterlady profile image
Manchesterlady
To view profiles and participate in discussions please or .
5 Replies
Lyndy profile image
Lyndy

Yes..it’s one of the Parp inhibitors like olaparib. Access is quite restricted to these very expensive new drugs. I am BRCA 1 and on my first recurrence. Usually olaparib is only offered with your third chemo. One option is to sign up to a trial. These drugs were developed with BRCA in mind but I think they are beginning to use them with non BRCA too now. xx

Spes profile image
Spes

The PARP inhibitors are used primarily as a maintenance treatment (same as Avastin) so you need to be in remission first before they will be considered as an option. There is evidence that they can extend remission.

Unless you're BRCA+ you're not currently likely to get one of these drugs as standard of care, hence the suggestion of trials. Generally you need to have had several lines of chemo and to be within a certain time frame of finishing the last platinum based one. I'm on Niraparib on a compassionate use scheme, but I've had 4 lines of chemo. NICE is appraising Niraparib currently, due to report in the summer.

Manchesterlady profile image
Manchesterlady in reply to

Thanks for your reply . I’m starting on carboplat next week . I am very frightened as how I’m going to be .

You'll be fine.

You may also like...

YOU can ask the experts 👍🏻

Hi ladies, Just seen this on FaceBook & thought I'd share. Some of you might wish to pose your own...

Ask the experts day in Manchester

interested in attending a day in Manchester on 5th June called ask the experts-Advances in...

Expert Patient Programme

Gemcitabine/Carboplatin question

ladies. Has anyone had weight rises while on Gemcitabin/Carboplatin. ,My weight is increasing about...

Treatment terminology question

would be third line? Just trying to make sense of the recent article from the US about niraparib.